Table 4.

Hereditary Folate Malabsorption: Supportive Care

Manifestation/ConcernTreatmentConsiderations/Other
Folate deficiency Folate replacement therapy
(See Targeted Therapy.)
Infants diagnosed before signs/symptoms appear should be treated immediately to prevent onset of folate deficiency & clinical manifestations.
Anemia/
Thrombocytopenia
Responds rapidly to folate replacement therapy w/hematopoietic response w/in a few days
  • On very rare occasions when transfusion is required, administer blood products appropriate to the person's immunologic status (e.g., washed packed red blood cells in those w/IgA deficiency).
  • Bleeding complications from thrombocytopenia have not been reported.
Immunodeficiency
  • Folate replacement therapy will rapidly correct immune deficiencies.
  • The most common infection, Pneumocystis jirovecii pneumonia, is treated w/trimethoprim-sulfamethoxazole.
Because of reports of onset of pneumocystis infection w/initiation of folate therapy, prophylaxis w/trimethoprim-sulfamethoxazole has been used prior to folate treatment. 1
Developmental delay /
Intellectual disability
Developmental services & educational support as needed
Seizures ASM is administered when seizures occur; per neurologist recommendations.Once seizures are well controlled & adequate CSF folate levels have been achieved, an attempt can be made to taper & discontinue ASM as guided by neurologist.

ASM = anti-seizure medication

1.

From: Hereditary Folate Malabsorption

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.